CAMBRIDGE, Mass., April 20, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will release its financial results for first quarter ended March 31, 2012 before the U.S. financial markets open on Thursday, May 3, 2012.
